Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I) (1300)
- Resource Type
- Abstract
- Authors
- Lee, Elizabeth; Rodon, Jordi; Demeure, Michael; Deming, Dustin; Federman, Noah; McKean, Meredith; Spira, Alexander; Kwiatkowski, David; Hussein, Maen; Gordon, Erlinda; Crockett, David; Ganjoo, Kristen; Schulte, Brian; Cranmer, Lee; Schmid, Anita; Navarro, Willis; Itri, Loretta; Iyer, Gopa
- Source
- In Gynecologic Oncology September 2023 176 Supplement 1:S185-S185
- Subject
- Language
- ISSN
- 0090-8258